Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Bhavana Bhat"'
Publikováno v:
Dysphagia. 38:457-465
Owing to differences in clinical approaches toward videofluoroscopic swallowing studies (VFSS), professional and governing bodies in some countries have implemented guidelines for performing VFSS. However, in India, the establishment of such practice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f4c7451a145128d7a0f0236e5df309d
https://doi.org/10.1007/s00455-022-10487-5
https://doi.org/10.1007/s00455-022-10487-5
Autor:
Mrunali Nandanwar, Eesha Shukla, Aswatha Ram H N, Venkatesh Kamath B, Bhavana Bhat B, Aravinda Pai, Kamesh Kumar Keshri
Publikováno v:
International Journal of Research in Pharmaceutical Sciences. 12:125-129
Asparaginase, derived from microbial origin hydrolyses L-asparagine to L-aspartic acid. The enzyme finds principal use in the treatment of Acute Lymphoblastic Leukemia during childhood that primarily occurs between two to ten years of age. L-Asparagi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b57f8ee1b6802545245db285883a962
https://doi.org/10.26452/ijrps.v12i1.3947
https://doi.org/10.26452/ijrps.v12i1.3947
Autor:
Aref Al‐Kali, Ibrahim Aldoss, Pamela J. Atherton, Carrie A. Strand, Bijal Shah, Jonathan Webster, Bhavana Bhatnagar, Karen S. Flatten, Kevin L. Peterson, Paula A. Schneider, Sarah A. Buhrow, Jianping Kong, Joel M. Reid, Alex A. Adjei, Scott H. Kaufmann
Publikováno v:
Cancer Medicine, Vol 12, Iss 23, Pp 21229-21239 (2023)
Abstract Background Despite recent approval of several new agents, relapsed acute lymphoblastic leukemia (ALL) remains challenging to treat. Sapanisertib (MLN0128/TAK‐228) is an oral TORC1/2 inhibitor that exhibited preclinical activity against ALL
Externí odkaz:
https://doaj.org/article/55ca42b54be149f0b8acb389ece68dc9
Autor:
Mark Litzow, Zhuoxin Sun, Ryan Mattison, Elisabeth Paietta, Charles Mullighan, Kathryn Roberts, Yanming Zhang, Janis Racevskis, Cheryl Willman, Matthew Wieduwilt, Michaela Liedtke, Julie Bergeron, Hillard Lazarus, Dan Arber, Brent Wood, Jacob Rowe, Keith Pratz, Shira Dinner, Noelle Frey, Steve Gore, Bhavana Bhatnagar, Ehab Atallah, Geoff Uy, Deepa Jeyakumar, Tara Lin, Shejal Patel, Michelle Elliott, Anjali Advani, Daniel Deangelo, Dimitrios Tzachanis, Pankit Vachhani, Rupali Bhave, Richard Little, Harry Erba, Richard Stone, Selina Luger, Martin Tallman
Publikováno v:
HemaSphere, Vol 7, p e1944062 (2023)
Externí odkaz:
https://doaj.org/article/4a4e6f30613c4e578971556fc0741d72
Autor:
Sangmin Lee, Sanjay Mohan, Jessica Knupp, Kamal Chamoun, Adrienne de Jonge, Fan Yang, Erkan Baloglu, Jatin Shah, Michael G. Kauffman, Sharon Shacham, Bhavana Bhatnagar
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-4 (2022)
Abstract Patients with higher-risk myelodysplastic syndromes (MDS) refractory to hypomethylating agents (HMAs) have limited therapeutic options and an expected overall survival (OS) of 3–5 months. Eltanexor is an investigational oral selective inhi
Externí odkaz:
https://doaj.org/article/45d616db3d9d47b9b350d3ed3b69c2ff
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Joshua F. Zeidner, Tara L. Lin, Carlos E. Vigil, Gil Fine, M. Yair Levy, Aziz Nazha, Jordi Esteve, Daniel J. Lee, Karen Yee, Andrew Dalovisio, Eunice S. Wang, Juan M. Bergua Burgues, Jeffrey Schriber, Mark R. Litzow, Olga Frankfurt, Teresa Bernal Del Castillo, Vijaya Raj Bhatt, Bhavana Bhatnagar, Priyanka Mehta, Richard Dillon, Maria Vidriales Vicente, Stephen Anthony, David Bearss, Pau Montesinos, B. Douglas Smith
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 10, Pp 1-5 (2021)
Externí odkaz:
https://doaj.org/article/7122a437fe1c4abaa373b01b87a4c63e
Autor:
Sooraj Sreenath, Nayanthara P. Sreelatha, Chetan M. Pawar, Vidhiben Dave, Bhavana Bhatt, Nitin G. Borle, Rajaram Krishna Nagarale
Publikováno v:
Membranes, Vol 13, Iss 6, p 574 (2023)
The quest for a cost-effective, chemically-inert, robust and proton conducting membrane for flow batteries is at its paramount. Perfluorinated membranes suffer severe electrolyte diffusion, whereas conductivity and dimensional stability in engineered
Externí odkaz:
https://doaj.org/article/09a8fb61b4a1436ab91f98ee1a7c25b2
Autor:
Alice S. Mims, Jessica Kohlschmidt, Uma Borate, James S. Blachly, Shelley Orwick, Ann-Kathrin Eisfeld, Dimitrios Papaioannou, Deedra Nicolet, Krzysztof Mrόzek, Eytan Stein, Bhavana Bhatnagar, Richard M. Stone, Jonathan E. Kolitz, Eunice S. Wang, Bayard L. Powell, Amy Burd, Ross L. Levine, Brian J. Druker, Clara D. Bloomfield, John C. Byrd
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-15 (2021)
Abstract Background Older patients (≥ 60 years) with acute myeloid leukemia (AML) often have multiple, sequentially acquired, somatic mutations that drive leukemogenesis and are associated with poor outcome. Beat AML is a Leukemia and Lymphoma Soci
Externí odkaz:
https://doaj.org/article/c4c6e83a72104dcd8a6a682632819213
Autor:
Bhavana Bhatnagar, Ramiro Garzon
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
MicroRNAs (miRs) are short non-coding RNAs, typically 18-25 nucleotides in length, that are critically important, through their direct effects on target mRNAs, in a variety of cellular processes including cell differentiation, proliferation and survi
Externí odkaz:
https://doaj.org/article/2238b176d2f3445299273f3db59c09c3